SEC Form D · filed July 1, 2024
NeuroBo Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Jason L. Groves · Cambridge, MADirectorAndrew L. Koven · Cambridge, MADirectorJames P. Tursi · Cambridge, MADirectorD. G. Strickland · Cambridge, MADirectorMarshall H. Woodworth · Cambridge, MAExecHyung H. Kim · Cambridge, MAExec · DirectorMark A. Glickman · Cambridge, MADirectorMichael L. Salsbury · Cambridge, MADirectorD. G. Strickland · Cambridge, MADirectorJason L. Groves · Cambridge, MADirectorAndrew L. Koven · Cambridge, MADirectorMarshall H. Woodworth · Cambridge, MAExecJames P. Tursi · Cambridge, MADirectorHyung H. Kim · Cambridge, MAExec · DirectorMichael L. Salsbury · Cambridge, MADirectorMark A. Glickman · Cambridge, MADirectorMichael W. Carter · New York, NYDirectorIlon R. Wu · New York, NYDirectorMark B. Fitzsimmons · New York, NYDirectorSteven M. Felsenthal · New York, NYDirectorGrant N. Smith · New York, NYDirectorGregg R. Buckbinder · New York, NYDirectorBarry A. Goodman · New York, NYExecJack Norris · New York, NYExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗